These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 13572936)

  • 1. Clinical evaluation of miradon.
    KELLAWAY G
    Br Med J; 1958 Oct; 2(5101):889-91. PubMed ID: 13572936
    [No Abstract]   [Full Text] [Related]  

  • 2. OUTPATIENT ANTICOAGULATION: A PROBLEM IN LONG-TERM MANAGEMENT.
    BEINSTEIN J
    Va Med Mon (1918); 1964 Apr; 91():149-54. PubMed ID: 14140408
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of anticoagulant therapy with anisindione (miradon).
    CONNELL WF; MAYER GA
    Can Med Assoc J; 1959 May; 80(10):785-90. PubMed ID: 13652026
    [No Abstract]   [Full Text] [Related]  

  • 4. ATTEMPTED REDUCTION OF ADHESIVE PLATELETS AFTER CARDIAC INFARCTION.
    EASTHAM RD
    Lancet; 1964 Sep; 2(7359):541-3. PubMed ID: 14172343
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation and treatment of disorders of the coronary circulation].
    HOCHREIN M
    Dtsch Med J; 1952 Sep; 3(17-18):390-7. PubMed ID: 13020640
    [No Abstract]   [Full Text] [Related]  

  • 6. Agranulocytosis during phenindione therapy.
    AGER JA; INGRAM GI
    Br Med J; 1957 May; 1(5027):1102-3. PubMed ID: 13426555
    [No Abstract]   [Full Text] [Related]  

  • 7. Coronary occlusion and myocardial infarction.
    CAPUTI A; BURNS LE
    R I Med J; 1953 May; 36(5):251-2. PubMed ID: 13056446
    [No Abstract]   [Full Text] [Related]  

  • 8. AN ASSESSMENT OF LONG-TERM ANTICOAGULANT ADMINISTRATION AFTER CARDIAC INFARCTION. SECOND REPORT OF THE WORKING PARTY ON ANTICOAGULANT THERAPY IN CORONARY THROMBOSIS TO THE MEDICAL RESEARCH COUNCIL.
    RICE-WRAY E
    Br Med J; 1964 Oct; 2(5413):837-43. PubMed ID: 14185634
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical experience experience with the anticoagulant anisindione (miradon).
    PAUL HA; ARSCOTT PM; KOPPEL JL; OLWIN JH
    Surg Gynecol Obstet; 1959 May; 108(5):605-15. PubMed ID: 13647217
    [No Abstract]   [Full Text] [Related]  

  • 10. CURRENT MYTHS AND REALITIES IN ANTICOAGULANT THERAPY FOR CORONARY HEART DISEASE.
    RUSSEK HI
    Med Clin North Am; 1964 Mar; 48():355-70. PubMed ID: 14149240
    [No Abstract]   [Full Text] [Related]  

  • 11. A preliminary report on the clinical use of a new anticoagulant (miradon).
    BLAUSTEIN A
    N Y State J Med; 1958 Mar; 58(5):701-2. PubMed ID: 13517546
    [No Abstract]   [Full Text] [Related]  

  • 12. Failure of phenindione to prevent intravascular clotting.
    DUTHIE HL; SMITH G
    Scott Med J; 1960 Jun; 5():265-6. PubMed ID: 13818900
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anticoagulant therapy of myocardial infarct and intractable angina pectoris].
    LENEGRE J; BEAUMONT JL
    Presse Med (1893); 1952 Oct; 60(66):1395-7. PubMed ID: 13027035
    [No Abstract]   [Full Text] [Related]  

  • 14. PROPHYLACTIC ANTICOAGULANT THERAPY FOR CORONARY ARTERY DISEASE. A SEVEN-YEAR CONTROLLED STUDY.
    SEAMAN AJ; GRISWOLD HE; REAUME RB; RITZMAN LW
    JAMA; 1964 Jul; 189():183-7. PubMed ID: 14149998
    [No Abstract]   [Full Text] [Related]  

  • 15. [Paradoxical reaction during coronary reperfusion in the acute stage of myocardial infarction].
    Sacrez A; Favier JP; Roman S; Mossard JM; Bareiss P
    Presse Med; 1987 Oct; 16(35):1759. PubMed ID: 2962091
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiac MRI evaluation of infarct size with thrombus aspiration during ST-segment elevation myocardial infarction.
    Varshney A; Martinez-Rumayor AA; Brilakis ES; Banerjee S
    J Invasive Cardiol; 2011 May; 23(5):177-8. PubMed ID: 21562343
    [No Abstract]   [Full Text] [Related]  

  • 17. [First results with nialamide in cardiovascular therapy].
    SCOPPOLA L; GANDINI L
    Minerva Med; 1959 Dec; 50():4442-7. PubMed ID: 14444188
    [No Abstract]   [Full Text] [Related]  

  • 18. Further observations on parenteral magnesium sulphate therapy in coronary heart disease: a clinical appraisal.
    MALKIEL-SHAPIRO B
    S Afr Med J; 1958 Dec; 32(51):1211-5. PubMed ID: 13624818
    [No Abstract]   [Full Text] [Related]  

  • 19. [Incidence of residual thrombi following successful thrombolytic therapy in acute myocardial infarct and their significance for the rate of early re-occlusion. A report of a multicenter dose-finding study for thrombolytic therapy with urokinase preactivated natural prourokinase (TCL 598)].
    Gulba DC; Bode C; Topp J; Höpp HW; Westhoff-Bleck M; Rafflenbeul W; Lichtlen PR
    Z Kardiol; 1990 Apr; 79(4):279-85. PubMed ID: 2113330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myocardial infarction--coronary thrombosis and salvage of the ischemic myocardium.
    Maroko PR; Ribeiro LG; Goldberg S
    Cardiovasc Clin; 1983; 14(1):191-201. PubMed ID: 6137280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.